{"id":"NCT06149104","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study","officialTitle":"A Multicenter, Open-label Study to Collect the Safety Information of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-12-04","primaryCompletion":"2024-08-14","completion":"2024-08-14","firstPosted":"2023-11-28","resultsPosted":"2025-02-18","lastUpdate":"2025-02-18"},"enrollment":8,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure"],"interventions":[{"type":"DRUG","name":"sacubitril/valsartan","otherNames":[]}],"arms":[{"label":"sacubitril/valsartan","type":"EXPERIMENTAL"}],"summary":"The purpose of this open-label study was to collect additional safety information of sacubitril/valsartan and to provide post-trial access to sacubitril/valsartan for the eligible Japanese patients who completed CLCZ696B2319E1(NCT03785405) study until marketed product of pediatric formulation, film-coated granules in capsule, is available in Japan.","primaryOutcome":{"measure":"Number of Participants With Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)","timeFrame":"Adverse events were reported from first dose of study treatment until end of study treatment, up to a maximum duration of approximately 8 months.","effectByArm":[{"arm":"Sacubitril/Valsartan","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":6,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":8},"commonTop":["Nasopharyngitis","Vomiting","Seasonal allergy","COVID-19","Gastroenteritis"]}}